Xianqiang Mi,
Professor,
Shanghai Advanced Research Institute Chinese Academy of Sciences
My research focuses on bio-probe and biosensor. My research findings mainly come from STCSM, NSFC, CAS and MOST. I have published over 80 articles and 16 patents. I have taken part in the new medical device regulation and related guidance documents revision work of CFDA since 2006 and actively involved in activities of GHTF, WHO, EUCTP and AHWP. I am the steering member of many academy and industry societies in China and medical device advisor of Chinese Academy of Sciences, Ministry of Science and Technology, CFDA and some medical device companies.
Point-of-Care Nano Biosensing Technology Based on Big Data
Wednesday, 28 September 2016 at 16:00
Add to Calendar ▼2016-09-28 16:00:002016-09-28 17:00:00Europe/LondonPoint-of-Care Nano Biosensing Technology Based on Big DataPoint-of-Care Diagnostics and Global Health World Congress 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
We are in the era of big data. Digitization of an individual’s ‘-omics’ data like genome, transcriptome, proteome and metabolome information parlays into big data’ informatics which could be used for healthcare. A lot of omics-based biomarkers have been identified. Point-of-care biosensor systems can potentially improve patient care through real-time and remote health monitoring. Our work mainly focus on potentially new technologies in the form of POC biosensors like electrochemical biosensor, fluorescence biosensor etc. We have developed the prototype of intelligent electrochemical microfluid diagnostics system as a potential candidate for point-of-care biosensing applications. In future, requirements such as rapid label-free detection, miniaturized sensor size, portability and wireless networking schemes for a point-of-care environment will be the focus of our work. We hope our nano biosensing system can detect significant omics based biomarkers and provide clinically relevant information in biological samples. , thereby assisting physicians and clinicians for health management. The context of POC approvals by the China FDA will also be discussed.
Add to Calendar ▼2016-09-26 00:00:002016-09-28 00:00:00Europe/LondonPoint-of-Care Diagnostics and Global Health World Congress 2016Point-of-Care Diagnostics and Global Health World Congress 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2016-09-28 16:00:002016-09-28 17:00:00Europe/LondonPoint-of-Care Nano Biosensing Technology Based on Big DataPoint-of-Care Diagnostics and Global Health World Congress 2016 in San Diego, California, USASan Diego, California, USASELECTBIOenquiries@selectbiosciences.com
